MYND Life Sciences Inc. Establishes Scientific Advisory Board
/PRNewswire/ - MYND Life Sciences Inc. (CSE: MYND) ("MYND"), a drug research and development company focused on novel psychedelic drug development, diagnostic...
Source: prnewswire.com
Marka Geyer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Marka Geyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Marka Geyer Today - Breaking & Trending Today
Mouse pups' cries give clues about autism spectrum disorder
E-Mail IMAGE: Noboru Hiroi, PhD, and collaborators are studying which mouse pup cries are most predictive of the pups developing autism spectrum disorder later. Dr. Hiroi is a professor at The University... view more Credit: The University of Texas Health Science Center at San Antonio SAN ANTONIO (May 27, 2021) -- One-fifth of babies who inherit a genetic variant located on chromosome 16 will develop autism spectrum disorder (ASD) by age 3. The variant is called 16p11.2 deletion. Noboru Hiroi, PhD, of The University of Texas Health Science Center at San Antonio (also referred to a...
Source: eurekalert.org
Bright Minds Biosciences Strengthens Scientific Advisory Team to Prepare for Future Growth
-- Key additions deepen drug development expertise and position the Company to advance pipeline --VANCOUVER, British Columbia, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds” or the “Company”), a biosciences company focused on creating the next generation of psychedelic and related therapies for the treatment of mental health and central nervous system disorders, today announced three additions to its scientific advisory team: John M. McCall, PhD, Senior Advisor; Mark A. Geyer, PhD, Advisor; and Uros Laban, Senior Chemist. “We are d...
Source: yahoo.com